Combined SGLT‐2 and ACE inhibition upregulates the renin‐angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double‐blind, placebo‐controlled exploratory trial

Corresponding Author

Chantal Kopecky PhD

Medical University of Vienna, Department of Internal Medicine III, Division of Nephrology and Dialysis, Vienna, Austria

University of New South Wales, Faculty of Medicine, School of Medical Sciences, Sydney, Australia

Correspondence

Chantal Kopecky, PhD, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.

View original article

0 0 0 0 0 0 0

Comments (0)